Anxiolytic, Sedative and Hypnotic Drugs Overview
40 Questions
1 Views

Anxiolytic, Sedative and Hypnotic Drugs Overview

Created by
@RealisticEiffelTower5175

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which drug type is primarily used to promote sleep?

  • Sedative drugs
  • Anticonvulsant drugs
  • Hypnotic drugs (correct)
  • Anxiolytic drugs
  • What is a common side effect of anxiety symptoms?

  • Hyperactivity
  • Palpitation (correct)
  • Fatigue
  • Increased appetite
  • Which of the following benzodiazepines is commonly used for anxiety relief?

  • Lithium
  • Alprazolam (correct)
  • Flurazepam
  • Buspirone
  • What parameter is NOT typically tested to determine the specific type of benzodiazepine?

    <p>Patient's age</p> Signup and view all the answers

    Which characteristic of benzodiazepines is more suitable for hypnotics?

    <p>Short half-life</p> Signup and view all the answers

    Which type of receptor is associated with benzodiazepines in the brain?

    <p>BZD1 receptor</p> Signup and view all the answers

    What is a potential therapeutic use of sedative-anxiolytic-hypnotic drugs beyond treating anxiety?

    <p>Muscle relaxation</p> Signup and view all the answers

    Which benzodiazepine is likely to have a longer duration of action?

    <p>Diazepam</p> Signup and view all the answers

    What is a primary effect of overdose on barbiturates?

    <p>Respiratory and circulatory failure</p> Signup and view all the answers

    Which of the following conditions is contraindicated for barbiturate use?

    <p>Pulmonary insufficiency</p> Signup and view all the answers

    What is a consequence of prolonged barbiturate usage?

    <p>Tolerance development</p> Signup and view all the answers

    What psychological effect may occur with regular barbiturate use?

    <p>Dependence and withdrawal syndrome</p> Signup and view all the answers

    How do barbiturates primarily affect the cardiovascular system?

    <p>They lower blood pressure by reducing cardiac output.</p> Signup and view all the answers

    What is the risk related to the use of barbiturates during pregnancy?

    <p>Depression of the fetus</p> Signup and view all the answers

    After how many hours does withdrawal syndrome from barbiturates typically begin?

    <p>8-38 hours</p> Signup and view all the answers

    What is a common adverse effect associated with chronic barbiturate use?

    <p>Coma with potential respiratory failure</p> Signup and view all the answers

    Which benzodiazepine is classified as short-acting?

    <p>Triazolam</p> Signup and view all the answers

    What is the half-life of alprazolam?

    <p>16 hours</p> Signup and view all the answers

    What is a potential consequence of using benzodiazepines during pregnancy?

    <p>Depression of the neonatal CNS after delivery</p> Signup and view all the answers

    What is the primary neurotransmitter that BZD receptors interact with to produce sedation?

    <p>GABA</p> Signup and view all the answers

    Which of the following is true regarding withdrawal symptoms from benzodiazepines?

    <p>They may appear after 2-4 days for alprazolam and lorazepam.</p> Signup and view all the answers

    Which action of BZDs is primarily associated with high doses?

    <p>Sedation and hypnosis</p> Signup and view all the answers

    Which benzodiazepine has the longest half-life among the following?

    <p>Flurazepam</p> Signup and view all the answers

    How does tolerance develop with benzodiazepine use?

    <p>Cross-tolerance can occur within the group.</p> Signup and view all the answers

    What therapeutic use of BZDs is indicated for treating children?

    <p>Somnambulism</p> Signup and view all the answers

    Which of the following properties is NOT associated with BZDs?

    <p>Analgesic action</p> Signup and view all the answers

    When does dependence typically appear with the use of short half-life benzodiazepines?

    <p>After a few weeks of use</p> Signup and view all the answers

    What is the role of active metabolites in long-acting benzodiazepines?

    <p>They prolong the drug's half-life.</p> Signup and view all the answers

    What is the safety profile of BZDs in terms of lethal and therapeutic doses?

    <p>Lethal dose is over 1000 times greater than therapeutic dose</p> Signup and view all the answers

    Which area of the brain do BZDs selectively inhibit to reduce anxiety?

    <p>Limbic system</p> Signup and view all the answers

    Which BZD function is primarily related to increasing presynaptic inhibition in the spinal cord?

    <p>Muscle relaxant action</p> Signup and view all the answers

    For which procedure are shorter-acting BZDs often used as premedication?

    <p>Endoscopic procedures</p> Signup and view all the answers

    What is the primary active intermediate produced from chloralhydrate in the body?

    <p>Trichloroethanol</p> Signup and view all the answers

    What is a potential effect of combining chloral with ethanol after prolonged use?

    <p>Hypotension</p> Signup and view all the answers

    Which drug is used primarily for short-term sedation and is an antihistamine?

    <p>Promethazine</p> Signup and view all the answers

    Which of the following acts on the BZ1 receptor and is not a benzodiazepine?

    <p>Zolpidem</p> Signup and view all the answers

    What is a likely consequence of rifampin co-administration with zolpidem?

    <p>Shortened half-life of zolpidem</p> Signup and view all the answers

    What forms when trichloroethanol is conjugated with glucuronic acid?

    <p>An inert form</p> Signup and view all the answers

    Which medication undergoes hepatic oxidation by the CYP450 system?

    <p>Zolpidem</p> Signup and view all the answers

    What is the expected duration of sleep induced by chloralhydrate?

    <p>6-8 hours</p> Signup and view all the answers

    Study Notes

    Anxiolytic, Sedative and Hypnotic Drugs

    • Overview:
      • Anxiolytics treat anxiety symptoms.
      • Sedatives calm patients without inducing sleep.
      • Hypnotics promote sleep.
      • These drugs can be used for anticonvulsant, antiepileptic, and muscle relaxant purposes.
    • Anxiety Symptoms: Include tachycardia, sweating, palpitations, tremor, trembling, gastrointestinal disorders, and sleep disturbances.
    • Benzodiazepines (BZDs):
      • Over 2000 benzodiazepines have been synthesized, with over 100 used clinically.
      • Common BZDs include alprazolam, chlorodiazepoxide, clonazepam, diazepam, estazolam, flurazepam, lorazepam, midazolam, oxazepam, temazepam, and triazolam.
      • Types are determined by:
        • Drug's half-life (t½).
        • Presence and half-life of active metabolites.
        • Speed of absorption, solubility, and passage into the CNS.
      • Long t½ BZDs/metabolites are suitable for anxiety treatment, while short t½ BZDs/metabolites are better for promoting sleep.
    • BZD Mechanism of Action:
      • BZDs interact with specific BZD1, BZD2, and BZD3 receptors in the brain.
      • These receptors are located near GABA receptors and chloride ion channels, forming a complex.
      • BZDs enhance GABA's inhibitory effect, leading to chloride channel opening, resulting in sedation.
    • Pharmacological Actions of BZDs:
      • Anxiolytic: BZDs reduce anxiety by inhibiting neuronal circuits in the limbic system at low doses.
      • Sedative and Hypnotic: All BZDs possess sedative properties, with some inducing hypnosis at higher doses.
      • Anticonvulsant: Some BZDs exhibit anticonvulsant activity, used to treat epilepsy.
      • Muscle Relaxant: BZDs relax skeletal muscle spasticity by increasing presynaptic inhibition in the spinal cord.
      • Amnesia: Short-acting BZDs are used as premedication for anxiety-provoking procedures to induce amnesia (e.g., endoscopy, bronchoscopy, dental).
    • Therapeutic Uses of BZDs:
      • Anxiety (with or without psychotic states).
      • Panic attacks.
      • Insomnia.
      • Alcohol withdrawal.
      • Sleepwalking (somnambulism) in children.
      • Muscle spasms from various causes (e.g., epilepsy).
      • Anesthesia and sedation for endoscopies.
    • BZD Safety and Pharmacology:
      • BZDs are relatively safe, with the lethal dose being over 1000 times higher than the therapeutic dose.
      • Sleep Disorders: Not all BZDs are effective hypnotics, but those commonly prescribed include:
        • Flurazepam (long-acting).
        • Temazepam (intermediate-acting).
        • Triazolam (short-acting).
      • Pharmacokinetics:
        • Absorption and distribution: BZDs are rapidly and fully absorbed orally, distributing throughout the body.
        • Duration of action: The half-life of BZDs determines their therapeutic usefulness.
          • Long-acting BZDs form active metabolites with long half-lives, leading to prolonged effects.
        • Tolerance and Dependence: Tolerance can develop with chronic use, with cross-tolerance among BZDs.
          • Dependence develops earlier with short t1/2 BZDs (e.g., alprazolam, lorazepam) compared to long t1/2 BZDs (e.g., diazepam).
    • Barbiturates:
      • Potent antidotes for convulsant drugs: Barbiturates can abolish convulsions arising from conditions like tetanus, eclampsia, and local anesthetic overdoses (e.g., procaine, cocaine).
      • Respiratory Depression: High doses of ultra-short-acting barbiturates induce death due to respiratory failure, caused by the depression of the respiratory center.
      • Cardiovascular effects: Hypnotic and anesthetic doses of barbiturates lower blood pressure by reducing cardiac output. Toxic doses can lead to heart failure.
      • Tolerance: Tolerance can develop within 14 days of continuous use, possibly due to enzyme induction.
      • Psychological and Physical Dependence: Regular doses of 0.4 g/day or more can lead to dependence.
        • Withdrawal symptoms start 8-38 hours after cessation and last 8-14 days.
          • Symptoms include anxiety, twitching, intention tremor, weakness, dizziness, visual distortion, nausea, delirium, convulsions, and coma.
      • Pharmacokinetics:
        • Barbiturates are absorbed orally and distributed throughout the body, from the brain to skeletal muscle and adipose tissues.
        • They readily cross the placenta and can depress the fetus.
        • Excretion is primarily hepatic, with little urinary excretion except for phenobarbital.
      • Contraindication:
        • Pulmonary insufficiency.
        • Hepatic failure.
        • Porphyria.
        • Elderly patients due to potential paradoxical effects (e.g., excitation, paranoia, suicidal tendency).
      • Acute Adverse Effects:
        • Coma.
        • Respiratory and circulatory failure, leading to renal failure.
        • Allergic reactions (especially with phenobarbital).
    • Trichloroethanol Derivatives:
      • Chloral hydrate: Converted in the body to active trichloroethanol by alcohol dehydrogenase, with hypnotic effects.
        • Gastric irritation can occur when diluted in water, but flavored solutions reduce irritation.
        • Induces sleep within 30 minutes, lasting 6-8 hours.
        • Trichloroethanol is inactivated by conjugation with glucuronic acid.
      • Other chloral derivatives: Triclofose and chloralbetaine are alternatives.
      • Drug Interactions:
        • Ethanol: Trichloroethanol competitively inhibits the conversion of ethanol to acetaldehyde, increasing ethanol plasma concentration.
          • Chronic chloral use followed by alcohol ingestion can cause vasodilation, hypotension, and tachycardia.
        • Warfarin: Enhances anticoagulant effect.
    • Other Hypnotic Drugs:
      • Antidepressants: Can be effective long-term for managing chronic anxiety disorders, particularly in patients with substance addiction or dependence.
      • Phenothiazines:
        • Promethazine: A long-acting hypnotic, especially in children. Also an H1 receptor antagonist (antihistamine).
        • Trimeprazine: Used for short-term sedation and hypnosis in children. Also an antihistamine.
      • Zolpidem:
        • New hypnotic drug, not a benzodiazepine structurally, but acts on BZD1 receptors.
        • As effective as flunitrazepam.
        • Rapid onset and short half-life, providing hypnotic effects for approximately 5 hours.
        • Metabolized by CYP450 system to inactive products.
        • Drugs that induce CYP450 (e.g., rifampin) shorten zolpidem's half-life.
        • Similar drugs in action: Zaleplon and eszopiclone.
      • Meprobamate and Chlormezanone: Centrally acting muscle relaxants with sedative-hypnotic effects.
      • Bromides:

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz covers essential information about anxiolytic, sedative, and hypnotic drugs, including their uses, symptoms of anxiety, and details about benzodiazepines. It discusses the classification of these drugs based on their pharmacokinetics and clinical applications. Perfect for students in pharmacology or medicine.

    More Like This

    Anxiolytic Drugs: Mechanism and Effects
    10 questions
    Anxiolytic Drugs and Their Effects
    8 questions

    Anxiolytic Drugs and Their Effects

    OptimisticJuxtaposition avatar
    OptimisticJuxtaposition
    Benzodiazepines and Anxiety Treatment
    8 questions
    Use Quizgecko on...
    Browser
    Browser